LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 113,271 | 126,704 | 135,292 | 36,082 | 42,749 |
| TOTAL | $114,743 | $127,545 | $136,136 | $37,162 | $44,820 |
| Non-Current Assets | |||||
| PPE Net | 2,047 | 1,732 | 1,751 | 1,510 | 659 |
| Intangibles | 0 | 0 | 0 | 57 | 57 |
| Other Non-Current Assets | 217 | 70 | 57 | 0 | 0 |
| TOTAL | $2,264 | $1,802 | $1,808 | $1,567 | $716 |
| Total Assets | $117,007 | $129,347 | $137,944 | $38,729 | $45,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,408 | 3,052 | 2,567 | 1,843 | 2,459 |
| Accrued Expenses | 2,763 | 1,768 | 1,774 | 695 | 117 |
| TOTAL | $5,171 | $4,820 | $4,341 | $2,538 | $2,576 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,171 | $4,820 | $4,341 | $2,538 | $2,576 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,254 | N/A | 18,242 | 15,252 | 15,251 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -545,007 | -528,526 | -516,693 | -506,219 | -495,569 |
| Other shareholders' equity | 6,643 | 6,643 | 6,643 | 6,654 | 6,654 |
| TOTAL | $111,836 | $124,527 | $133,603 | $36,191 | $42,960 |
| Total Liabilities And Equity | $117,007 | $129,347 | $137,944 | $38,729 | $45,536 |